Issued Patents All Time
Showing 1–25 of 75 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12372536 | Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof | Robert Arch, Michelle Mader, Tetsuya Ishino, Joel Bard, William James Jonathan Finlay +6 more | 2025-07-29 |
| 12324835 | mRNA vaccine encoding fusion antigen against Mpox and severe acute respiratory syndrome coronavirus 2 | Yilong Yang, Wei-Ming Chen, Junjie Xu, Xiaofan Zhao, Lihua Hou +2 more | 2025-06-10 |
| 12234234 | Method for synthesizing 1,7-naphthyridine derivatives | Wei Qian, Yuhua Shi, Xing Huang, Changming Dong, Junkui Dang +6 more | 2025-02-25 |
| 12110337 | Anti-CD27 antibodies and uses thereof | Li-Sheng Lu, Mark J. Selby, Alan J. Korman, Shrikant Deshpande, Mohan Srinivasan +4 more | 2024-10-08 |
| 12097251 | Human papilloma virus type 51 L1 protein mutants | Shaowei Li, Daning Wang, Jie Chen, Ying Gu, Ningshao Xia | 2024-09-24 |
| 12076367 | Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide | Tianci Luo | 2024-09-03 |
| 11918650 | Pharmaceutical composition comprising bispecific antibody constructs for improved storage and administration | Jeff Abel, Lingwen Cui, Devrishi Goswami, Joon Huh, Bharadwaj Jagannathan +5 more | 2024-03-05 |
| 11793844 | Virus for treatment of tumor | Tong Cheng, Wei Wang, Junkai Wan, Wenkun FU, Xiangzhong Ye +1 more | 2023-10-24 |
| 11773385 | High-affinity human ACE2 construct for use in diagnosing and treating coronaviruses | Bing Chen, Tianshu Xiao, Yongfei Cai | 2023-10-03 |
| 11732266 | RNAi constructs for inhibiting ASGR1 expression and methods of use thereof | Michael OLLMANN, Yang Li, Oliver HOMANN, Leslie P. Miranda, Justin K. MURRAY +5 more | 2023-08-22 |
| 11707496 | Echovirus for treatment of tumors | Tong Cheng, Wei Wang, Junkai Wan, Longfa XU, Xiangzhong Ye +1 more | 2023-07-25 |
| 11680248 | Recombinant herpes simplex virus and use thereof | Chenghao Huang, Yong Luo, Quan Yuan, Ningshao Xia | 2023-06-20 |
| RE49431 | RNA interference agents for GST-PI gene modulation | Kenjirou Minomi, Hirokazu Takahashi, Erika Terada, Jens Harborth, Mohammad Ahmadian +1 more | 2023-02-28 |
| 11474112 | Tumor necrosis factor-like ligand 1A specific antibodies and compositions and uses thereof | Robert Arch, Michelle Mader, Tetsuya Ishino, Joel Bard, William James Jonathan Finlay +6 more | 2022-10-18 |
| 11427618 | Mutant of L1 protein of human papillomavirus type 39 | Shaowei Li, Daning Wang, Zhiping Wang, Xinlin Liu, Ningshao Xia | 2022-08-30 |
| 11339194 | Truncated rotavirus VP4 protein and application thereof | Shengxiang Ge, Tingdong Li, Lianzhi Jia, Yijian Li, Miaoge Xue +3 more | 2022-05-24 |
| 11326170 | Immunomodulatory polynucleotides and uses thereof | Tao Huang, Yan Shao | 2022-05-10 |
| 11103583 | Lipids for therapeutic agent delivery formulations | Joseph E. Payne, John A. Gaudette, Zheng Hou, Mohammad Ahmadian, Lei Yu +6 more | 2021-08-31 |
| 11045488 | RNA interference agents for GST-π gene modulation | Kenjirou Minomi, Hirokazu Takahashi, Erika Terada, Jens Harborth, Mohammad Ahmadian +1 more | 2021-06-29 |
| 10987418 | Polypeptide carrier for presenting target polypeptide and uses thereof | Tianying ZHANG, Quan Yuan, Xueran Guo, Minxi Wei, Xiaozhen Kang +1 more | 2021-04-27 |
| 10946063 | Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide | Tianci Luo | 2021-03-16 |
| 10870856 | RNAi constructs for inhibiting ASGR1 expression and methods of use thereof | Michael OLLMANN, Yang Li, Oliver HOMANN, Leslie P. Miranda, Justin K. MURRAY +4 more | 2020-12-22 |
| 10723767 | Truncated rotavirus VP4 protein and application thereof | Shengxiang Ge, Tingdong Li, Lianzhi Jia, Yijian Li, Miaoge Xue +3 more | 2020-07-28 |
| 10689434 | Antibody against hepatitis B surface antigen and use thereof | Wenxin Luo, Bing Zhou, Juan Zhang, Quan Yuan, Tianying ZHANG +1 more | 2020-06-23 |
| 10548973 | Polypeptide carrier for presenting target polypeptide and uses thereof | Tianying ZHANG, Quan Yuan, Xueran Guo, Ying Zhang, Qinjian Zhao +1 more | 2020-02-04 |